<DOC>
	<DOCNO>NCT01954940</DOCNO>
	<brief_summary>Whole-body vibration therapy ( WBVT ) novel , non-pharmacological intervention aim improve muscle strength endurance well bone density . It hold promise child neuromuscular disorder Duchenne muscular dystrophy ( DMD ) since muscle weakness result muscle breakdown also physical inactivity muscle disuse atrophy . Weak DMD patient may increasingly limit physical activity due fear fall loss independence ( e.g . difficulty rise stand without assistance ) . Prolonging length time boys DMD ambulatory important delaying complication disease ( lung hypoventilation , scoliosis ) well maintain bone health . We propose conduct pilot study WBVT young boy Duchenne muscular dystrophy ( DMD ) . The primary outcome document safety feasibility WBVT patient population . The secondary outcome evaluate change muscle strength endurance . Bone health also examine part routine clinical care . The study include 20 ambulatory boy DMD ; patient randomize ( 1:1 allocation ) 2 group : WBVT treatment WBVT treatment ( control ) . Treatment group consist 10 boy undergoing daily WBVT 8-week , open-label trial .</brief_summary>
	<brief_title>Whole Body Vibration Therapy Boys With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>1 . Diagnosis Duchenne muscular dystrophy confirm least one following : Dystrophin immunofluorescence and/or immunoblot show complete dystrophin deficiency , clinical presentation consistent typical DMD Positive gene deletion test ( miss one exon ) central rod domain ( exon 2560 ) dystrophin , read frame predict `` outofframe '' , clinical presentation consistent typical DMD Complete dystrophin gene sequence show alteration ( point mutation , duplication , mutation result stop codon mutation ) definitively associate DMD , clinical presentation consistent typical DMD 2 . Age 5 14 yr old ( inclusive ) 3 . Positive Gower sign ( indicate ability rise floor &amp; presence proximal muscle weakness ) . 4 . Able walk 10 meter &lt; 12 second 5 . Able stand upon WBVT plate ( knee flex ) entire treatment protocol ( i.e . 15minutes ) 6 . Stable absolute dose glucocorticoid ( i.e . prednisone deflazacort ) least 3 month prior 7 . Stable absolute dos medication may affect muscle function ( i.e . coenzyme Q10 , green tea extract , creatine , arginine , glutamine , nutritional supplement , etc . ) least 3 month prior 8 . Stable absolute dose medication may affect bone metabolism ( i.e . vitamin D calcium supplementation ) least 3 month prior 1 . Clinical presentation , genetic test and/or muscle biopsy consistent Becker muscular dystrophy 2 . History recent surgery ( within past 6months ) 3 . History recent fracture ( longbone vertebral ) within past 6months . 4 . Acute inflammatory process low extremity ( e.g . cellulitis , etc ) due risk pain and/or worsen inflammatory process 5 . History venous thrombosis ( theoretically risk induce thromboembolic event ) . 6 . History kidney bladder stone 7 . History uncontrolled seizure severe migraine 8 . History cardiac arrhythmia 9 . Intracranial pathology hardware ( e.g . ventriculoperitoneal shunt , cochlear implant ) . 10 . Use investigational experimental product within last 6months and/or concomitant participation another study 11 . Inability refusal follow study requirement ( e.g . autism , severe cognitive behaviour problem ) 12 . Inability refusal provide inform consent ( parent ) and/or assent ( child )</criteria>
	<gender>Male</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Whole body vibration therapy , muscle strength testing , bone health , ambulatory , endurance .</keyword>
</DOC>